| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |